Werner Meier
Direttore Tecnico/Scientifico/R&S presso Revitope Oncology, Inc.
Profilo
Werner Meier is associated with Revitope Oncology, Inc. as the Chief Scientific Officer & Director and with Revitope Ltd.
as a Director since 2019.
Posizioni attive di Werner Meier
Società | Posizione | Inizio |
---|---|---|
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - |
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Direttore/Membro del Consiglio | 02/01/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Health Services |
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Commercial Services |
- Borsa valori
- Insiders
- Werner Meier